Barrett esophagus: an update (Q37762151)

22 August 2017

1 reference

title

Barrett esophagus: an update (English)

1 reference

22 August 2017

Rami J Badreddine

1

1 reference

PubMed ID

20517288

22 August 2017

Kenneth K Wang

series ordinal

2

1 reference

PubMed ID

20517288

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

Nature Reviews Gastroenterology & Hepatology

22 August 2017

1 reference

22 August 2017

7

1 reference

22 August 2017

7

1 reference

22 August 2017

369-378

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2010.78

22 August 2017

0 references

cites work

Narrow band imaging in gastroesophageal reflux disease and Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Predicting presence of intestinal metaplasia and dysplasia in columnar-lined esophagus: a multivariate analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M Criteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Barrett esophagus: histology and pathology for the clinician

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Esophageal pH exposure and epithelial cell differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Review article: what I do now to manage adenocarcinoma risk, and what I may be doing in 10 years' time

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Prevalence of Barrett's esophagus in asymptomatic individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Barrett's esophagus: prevalence in symptomatic relatives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Familial clustering of reflux symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Polymorphisms of glutathione S-transferase M1, T1 and P1 in patients with reflux esophagitis and Barrett's esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Mitochondrial perturbation attenuates bile acid-induced cytotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Bile acids as carcinogens in human gastrointestinal cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Activation of the promoters of genes associated with DNA damage, oxidative stress, ER stress and protein malfolding by the bile salt, deoxycholate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Helicobacter pylori infection and Barrett's esophagus: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Obesity and Barrett's oesophagus: more than just reflux

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Abdominal obesity and the risk of Barrett's esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Association between body mass and adenocarcinoma of the esophagus and gastric cardia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

The epidemiology of obesity and gastrointestinal and other diseases: an overview

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Barrett's Esophagus and Obesity: The Missing Part of the Puzzle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

The association between body mass index and Barrett's esophagus: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Abdominal obesity and body mass index as risk factors for Barrett's esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Central adiposity and risk of Barrett's esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Leptin and the risk of Barrett's oesophagus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Association of adiponectin multimers with Barrett's oesophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

A pro-inflammatory genotype predisposes to Barrett's esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Inflammatory gradient in Barrett's oesophagus: implications for disease complications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Duodenal-content reflux into the esophagus leads to expression of Cdx2 and Muc2 in areas of squamous epithelium in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Cdx2 as a Marker of Epithelial Intestinal Differentiation in the Esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Novel findings in the pathogenesis of esophageal columnar metaplasia or Barrett's esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Screening for esophagitis and Barrett's esophagus with wireless esophageal capsule endoscopy: a multicenter prospective trial in patients with reflux symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Chromoendoscopy and narrow-band imaging compared with high-resolution magnification endoscopy in Barrett's esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Mucosal morphology in Barrett's esophagus: interobserver agreement and role of narrow band imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

The utility of narrow band imaging in improving the endoscopic diagnosis of gastroesophageal reflux disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Narrow-band imaging with magnification in Barrett's esophagus: validation of a simplified grading system of mucosal morphology patterns against histology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Autofluorescence and narrow-band imaging endoscopy for detecting early-staged cancer in Barrett's esophagus: a case report.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Confocal laser endoscopy: new approach to the early diagnosis of tumors of the esophagus and stomach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Confocal laser endomicroscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Confocal laser endomicroscopy for gastrointestinal diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Confocal laser endomicroscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Technology insight: confocal laser endoscopy for in vivo diagnosis of colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Endoscopic confocal imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

In vivo histopathology for detection of gastrointestinal neoplasia with a portable, confocal miniprobe: an examiner blinded analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

A fluorescence confocal endomicroscope for in vivo microscopy of the upper- and the lower-GI tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Identification of predictive factors for early neoplasia in Barrett's esophagus after autofluorescence imaging: a stepwise multicenter structured assessment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Autofluorescence endoscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Mortality study of 18 000 patients treated with omeprazole.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Aspirin and reduced risk of esophageal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Acid has antiproliferative effects in nonneoplastic Barrett's epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Radiofrequency ablation in Barrett's esophagus with dysplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.78

Confocal endomicroscopy: in vivo diagnosis of neoplastic lesions of the gastrointestinal tract.

31 March 2020

1 reference

12 December 2020

Magnifying endoscopy with narrow-band imaging or confocal laser endomicroscopy for in vivo rapid diagnostic of Barrett's esophagus

1 reference

12 December 2020

Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease

1 reference

12 December 2020

An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma

1 reference

12 December 2020

Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.

1 reference

12 December 2020

The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus.

1 reference

12 December 2020

Stem cells of the oesophageal epithelium

1 reference

12 December 2020

Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression?

1 reference

12 December 2020

Aspirin use and risk of fatal cancer

1 reference

12 December 2020

Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study.

1 reference

12 December 2020

Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence

1 reference

12 December 2020

Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRGASTRO.2010.78

1 reference

22 August 2017

1 reference

PubMed ID

20517288